| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 06/25/2008 | EP1934186A2 Renin inhibitors nitroderivatives |
| 06/25/2008 | EP1934180A2 3-cyclyl-2-(4-sulfamoyl-phenyl)-n-cyclyl-propionamide derivatives useful in the treatment of impaired glucose tolerance and diabetes |
| 06/25/2008 | EP1802576B1 Process for producing enantiomer of amlodipine in high optical purity |
| 06/25/2008 | CN101208352A Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| 06/25/2008 | CN101208303A CGRP receptor antagonists |
| 06/25/2008 | CN101208302A Novel 4-aminopiperidine derivatives as plasmepsin ii inhibitors |
| 06/25/2008 | CN101205211A Method for preparing hydrochloric paroxetine key intermediates |
| 06/25/2008 | CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 06/25/2008 | CN100396668C Non-imidazole aryloxypiperidines |
| 06/24/2008 | US7390924 Terphenyl derivatives, preparation thereof, compositions containing same |
| 06/24/2008 | US7390907 Vanilloid receptor ligands and their use in treatments |
| 06/24/2008 | US7390906 Forming ketone intermediates to terfenadine carboxylic acid metabolite; by use of pure regioisomer of 4-(Cyclopropyl-oxo-methyl)-alpha,alpha-dimethylphenylacetic acid |
| 06/24/2008 | US7390905 Tachykinin receptor antagonists for use treating e.g. emesis, depression, urinary disorder |
| 06/24/2008 | US7390904 Hydrogen peroxide catalyzed process for the preparation of sterically hindered N-hydrocarbyloxyamines |
| 06/24/2008 | US7390830 MIP-1 alpha and/or MCP-1 antagonists; rheumatoid arthritis; nephritis; multiple sclerosis; nephropathy |
| 06/24/2008 | US7390823 Use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or prevention of all mood disorders, adaptation disorders or mixed anxiety-depression disorders |
| 06/24/2008 | US7390803 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; monocyte chemoattractant protein (MCP) receptor antagonist; antiinflammatory agent; antiallergen; autoimmune diseases; rhinitis, dermatitis, asthma |
| 06/24/2008 | US7390433 Benzene derivative having long, linear conjugated structure, process for producing benzene derivative, and liquid-crystal material |
| 06/19/2008 | WO2008073623A2 Soluble epoxide hydrolase inhibitors |
| 06/19/2008 | WO2008072836A1 Inclusion complex comprising clopidogrel |
| 06/19/2008 | WO2008072703A1 Biphenylamide derivative |
| 06/19/2008 | WO2008071451A1 Dihydropyridine derivatives useful as protein kinase inhibitors |
| 06/19/2008 | WO2008071421A1 Nitrate esters of carbonic anhydrase inhibitors |
| 06/19/2008 | WO2008071398A1 Sulfonamides and their use as a medicament |
| 06/19/2008 | WO2008051875A3 Adamantylurea compounds as soluble epoxide hydrolase inhibitors |
| 06/19/2008 | WO2008051873A3 Phenylurea compounds as soluble epoxide hydrolase inhibitors |
| 06/19/2008 | WO2008016643A3 Certain chemical entities, compositions, and methods |
| 06/19/2008 | US20080146813 Grignard reagent (such as 4-alkylphenylmagnesium bromide) is added to a 3-cyanopyridinium salt (such as N-phenyloxycarbonyl-3-cyanopyridinium chloride) to get a 1,2-dihydropyridine which is oxidized with o-chloronil to obtain the 2-(4'-alkylphenyl)-5-cyanopyridine; display system |
| 06/19/2008 | US20080146740 Process for the controlled increase in the molecular weight of polyethylenes |
| 06/19/2008 | US20080146649 Substituted pyrrolidine and related compounds |
| 06/19/2008 | US20080146620 Dibenzylamine Compounds and Pharmaceutical Use Thereof |
| 06/19/2008 | US20080146612 Novel Biaromatic Compounds, Inhibitors of the P2X7-Receptor |
| 06/19/2008 | US20080146572 N-sulfonylurea apoptosis promoters |
| 06/19/2008 | US20080146569 Nicotinamide Derivatives |
| 06/19/2008 | US20080145907 used for immobilization of amine-containing materials such as amino acid, peptide, protein, enzyme, immunoglobulin, DNA, RNA or fragments to substrate surfaces |
| 06/19/2008 | CA2672167A1 Dihydropyridine derivatives as useful as protein kinase inhibitors |
| 06/19/2008 | CA2650329A1 Terephthalamate compounds and compositions, and their use as hiv integrase inhibitors |
| 06/18/2008 | EP1932830A1 Sulfonamides and their use as a medicament |
| 06/18/2008 | EP1931652A2 Amido compounds and their use as pharmaceuticals |
| 06/18/2008 | CN101203509A Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity |
| 06/18/2008 | CN101203508A Substituted pyrr0lidin-2-0nes , piperidin-2-0nes and isothiazolidine-1, 1-dioxides, their use as kvl .5 potassium channel blockers and pharmaceutical preparations comprising them |
| 06/18/2008 | CN101203492A Substituted butyrophenone derivatives |
| 06/18/2008 | CN100395236C Piperazine and piperidine derivatives for treatment of neurological diseases |
| 06/17/2008 | US7388118 Amine 1,2- and 1,3-diol compounds |
| 06/17/2008 | CA2439152C Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 06/17/2008 | CA2302347C 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oles, processes for their preparation and their use for medicaments |
| 06/17/2008 | CA2284732C Analogs of cocaine |
| 06/12/2008 | WO2008069469A1 Crystalline s-(-)-amlodipine camsylate anhydride and preparation method thereof |
| 06/12/2008 | WO2008068540A1 New benzamide derivatives as bradykinin antagonists |
| 06/12/2008 | WO2008068423A2 P<0}{0pyrrol derivatives, preparation and use of the same in therapy<0} |
| 06/12/2008 | WO2008042688A3 Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 |
| 06/12/2008 | WO2007148208A3 Carbonylated (aza) cyclohexanes as dopamine d3 receptor ligands |
| 06/12/2008 | WO2007123910A3 Copper-mediated functionalization of aryl c-h bonds, and compounds related thereto |
| 06/12/2008 | US20080139817 Reacting 2-chloro-3-cyanopyridine with benzyl mercaptan in the presence of a sodium carbonate and an aprotic solvent; hydrolyzing resulting intermediate; no need for purification |
| 06/12/2008 | US20080139811 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection |
| 06/12/2008 | US20080139630 Tissue-selective androgen receptor modulators (SARMs); male hypogonadism, prostate cancer, benign prostate hyperplasia, sarcopenia, rheumatoid arthritis and osteoarthritis; N-((5-cyclopropyl-2-fluoropyridin-3-yl)methyl)-2-phenylbutanamide for example |
| 06/12/2008 | US20080139627 Heterocyclic amide and imine derivatives, processes for their preparation, compositions comprising them and their use as pesticides |
| 06/12/2008 | US20080139625 Pyrrolidin-2-One and Piperidin-2-One Derivatives as 11-Beta Hydroxysteroid Dehydrogenase Inhibitors |
| 06/12/2008 | US20080139607 Inhibitors of the serine protease PAI-1 (plasminogen activator inhibitor type 1); (3R)-8-(3,4-Difluoro-phenyl)-7-heptyl-5-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyridine-3-carboxylic acid for example; desulfurization to form corresponding 1-(1-carboxyethyl)-1,2-dihydro-2-oxopyridine compound; coadministering |
| 06/12/2008 | US20080139575 Certain chemical entities, compositions, and methods |
| 06/12/2008 | US20080139564 Substituted phenyl propyl amines as histamine h3 receptor and serotonin transporter modulators |
| 06/12/2008 | US20080139505 Potentiators Of Glutamate Receptors |
| 06/12/2008 | CA2671749A1 Bicyclic compounds and uses as antidiabetics |
| 06/12/2008 | CA2671121A1 Stat3 inhibitor having anti-cancer activity and associated methods |
| 06/12/2008 | CA2669996A1 Pyrrol derivatives, preparation and use of the same in therapy |
| 06/11/2008 | EP1930330A1 Pleuromutilin derivatives as antimicrobials |
| 06/11/2008 | EP1930323A1 Biphenyl compounds useful in the synthesis of muscarinic receptor antagonists |
| 06/11/2008 | EP1930322A1 1-(4-piperidinyl)-1,3-dihydro-2H-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and ORL1 ligands for the treatment of pain |
| 06/11/2008 | EP1930308A1 Pharmaceutical agents for the treatment of cerebral amyloidosis |
| 06/11/2008 | EP1930021A2 Novel amide derivatives as growth hormone secretagogues |
| 06/11/2008 | EP1928875A1 2-amino-7,8-dihydro-6h-pyridoý4,3-d¨pyrimidin-5-ones |
| 06/11/2008 | EP1928829A1 Piperidine derivatives as antagonists of the cc chemokine receptor ccr1 and their use as anti-inflammatory agents |
| 06/11/2008 | EP1928821A1 Carboxamide derivatives as muscarinic receptor antagonists |
| 06/11/2008 | EP1485348B1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/11/2008 | EP1414794B1 Allylmercaptocaptopril compounds and uses thereof |
| 06/11/2008 | CN101198604A NPY antagonists, preparation and use |
| 06/11/2008 | CN101198584A Benzamide derivatives and uses related thereto |
| 06/11/2008 | CN101198583A Compounds which inhibit beta-secretase activity and methods of use |
| 06/11/2008 | CN101195614A Production of balofloxacin and purification process thereof |
| 06/11/2008 | CN101195602A 1-deoxidization nojiri toxin derivant, production method and uses thereof |
| 06/11/2008 | CN100393700C Cathepsin cysteine protease inhibitors |
| 06/10/2008 | US7385063 Method for preparing imidazole derivatives |
| 06/10/2008 | US7385060 4-Methylpropiophenone is reacted with piperidine hydrochloride and 1,3-dioxolane in the presence of an acid serving as a catalyst, and the tolperisone obtained in the form of an acid addition salt is separated by filtering after the reaction mixture has cooled down; improved purity, simplification |
| 06/10/2008 | US7385059 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators |
| 06/10/2008 | US7384967 Aryl carbonyl derivatives as therapeutic agents |
| 06/10/2008 | US7384945 Indole or benzimidazole derivatives as CB1 inverse agonists |
| 06/10/2008 | US7384944 Organ grafting; antiarthritic agents; inflammatory bowel disease |
| 06/10/2008 | US7384929 N-aryl azaspiroalkene and azaspiroalkane compounds and methods of preparation and use thereof |
| 06/10/2008 | CA2393995C Novel benzene sulfonamide derivatives, their preparation and pharmaceutical compositions containing them |
| 06/10/2008 | CA2371827C Amide compounds for the potentiation of cholinergic activity |
| 06/10/2008 | CA2227607C Penicillaminamide derivatives |
| 06/10/2008 | CA2129046C Opioid diarylmethylpiperazines and piperidines |
| 06/05/2008 | WO2008066708A2 New process for remifentanil synthesis |
| 06/05/2008 | WO2008065424A1 Ramipril-amlodipine salt |
| 06/05/2008 | WO2006138508B1 Benzamide derivatives and uses related thereto |
| 06/05/2008 | US20080132705 Process for the preparation of 2-substituted-5-(1-alkylthio)alkylpyridines |
| 06/05/2008 | US20080132683 Purification of immunoglobulins from solution (hybridoma cell culture supernatants, animal plasma or sera, or colostrum); solid phase synthesis |
| 06/05/2008 | US20080132552 e.g. N-[1-(3,5-Difluoro-benzyl)-2-hydroxy-3-methylamino-propyl]-5-methyl-N',N'-dipropyl-isophthalamide; beta-secretase inhibitor; neurodegenerative diseases: Alzheimer's disease |
| 06/05/2008 | US20080132543 Therapeutic and Delivery Methods of Prostaglandin Ep4, Agonists |
| 06/05/2008 | US20080132539 e.g. 2-amino-5-[(naphthalen-1-ylmethyl)-aminocarbonyl]-pentanoic acid hydroxyamide; advanced glycosylation endproducts inhibitor; diabetic neurosis, diabetic retinopathy, atherosclerosis, cataract, Alzheimer's disease, rheumatic arthritis, osteoarthritis, chronic renal failure; food and cosmetics |